SAS Cargo announced it was able to achieve its IATA CEIV Pharma re-certification.

Due to ongoing coronavirus restrictions, SAS Cargo said the audit process for re-certification was carried out remotely.

“In the middle of a global pandemic, those challenges are greatly exacerbated, while the need for the safe transport of potentially life-saving products is even more pressing. But we are a resilient industry, and we always will find solutions to put safety first," said Nick Careen, IATA’s senior vice president of airport, passenger, cargo and security (APCS).

“We congratulate SAS Cargo on successfully completing their CEIV Pharma re-certification, offered by IATA in a stringent remote process to ensure continued gold-standard transport and handling of this critical cargo, even in these tough times”.

Leif Rasmussen, president and chief executive of SAS Cargo, said the COVID-19 pandemic revealed that “it has never been more crucial meeting the specific needs of the life science and health care industry than now.”

“During Covid-19 airfreight has been a vital partner in delivering much-needed medicines, medical and protective equipment, as well as keeping global supply chains functioning for the most time- and temperature-sensitive goods,” said Rasmussen.

“By receiving the re-certification for IATA CEIV Pharma we clearly demonstrate our continuous focus on delivering the highest quality and being a reliable partner for transporting temperature-sensitive products”.